Literature DB >> 19302527

Engagement of Penicillium marneffei conidia with multiple pattern recognition receptors on human monocytes.

Yuttana Srinoulprasert1, Piyapong Pongtanalert, Runglawan Chawengkirttikul, Sansanee C Chaiyaroj.   

Abstract

P. marneffei is a thermal dimorphic fungus which causes penicilliosis, an opportunistic infection in immunocompromised patients in South and Southeast Asia. Little is known about the innate immune response to P. marneffei infection. Therefore, the initial response of macrophages to P. marneffei conidia was evaluated by us. Adhesion between monocytes from healthy humans and fungal conidia was examined and found to be specifically inhibited by MAbs against PRR, such as MR, (TLR)1, TLR2, TLR4, TLR6, CD14, CD11a, CD11b, and CD18. To study the consequences of these interactions, cytokines were also examined by ELISA. Binding of P. marneffei conidia to monocytes was significantly inhibited, in a dose-dependent manner, by MAbs against MR, TLR1, TLR2, TLR4, TLR6, CD14, CD11b and CD18. When monocytes were co-cultured with the conidia, there was an increase in the amount of surface CD40 and CD86 expression, together with TNF-alpha and IL-1beta production, compared to unstimulated controls. In assays containing anti-TLR4 or anti-CD14 antibody, reduction in the amount of TNF-alpha released by monocytes stimulated with P. marneffei conidia was detected. In addition, it was found that production of TNF-alpha and IL-1beta from adherent peripheral blood monocytes was partially impaired when heat-inactivated autologous serum, in place of untreated autologous serum, was added to the assay. These results demonstrate that various PRR on human monocytes participate in the initial recognition of P. marneffei conidia, and the engagement of PRR could partly initiate proinflammatory cytokine production.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302527     DOI: 10.1111/j.1348-0421.2008.00102.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  7 in total

1.  Innate Immunity Acts as the Major Regulator in Talaromyces marneffei Coinfected AIDS Patients: Cytokine Profile Surveillance During Initial 6-Month Antifungal Therapy.

Authors:  Rong-Jing Dong; Yun-Gui Zhang; Lei Zhu; Heng-Li Liu; Jun Liu; Yi-Qun Kuang; Rui-Rui Wang; Yu-Ye Li
Journal:  Open Forum Infect Dis       Date:  2019-04-26       Impact factor: 3.835

2.  Murine Macrophage Requires CD11b to Recognize Talaromyces marneffei.

Authors:  Yongxuan Hu; Sha Lu; Liyan Xi
Journal:  Infect Drug Resist       Date:  2020-03-27       Impact factor: 4.003

3.  Characterization of a novel yeast phase-specific antigen expressed during in vitro thermal phase transition of Talaromyces marneffei.

Authors:  Kritsada Pruksaphon; Mc Millan Nicol Ching; Joshua D Nosanchuk; Anna Kaltsas; Kavi Ratanabanangkoon; Sittiruk Roytrakul; Luis R Martinez; Sirida Youngchim
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

Review 4.  Talaromyces marneffei Infection: Virulence, Intracellular Lifestyle and Host Defense Mechanisms.

Authors:  Kritsada Pruksaphon; Joshua D Nosanchuk; Kavi Ratanabanangkoon; Sirida Youngchim
Journal:  J Fungi (Basel)       Date:  2022-02-19

Review 5.  Key thermally dimorphic fungal pathogens: shaping host immunity.

Authors:  Maxine A Höft; Lucian Duvenage; J Claire Hoving
Journal:  Open Biol       Date:  2022-03-09       Impact factor: 6.411

6.  Importance of adhesins in virulence of Paracoccidioides spp.

Authors:  Haroldo C de Oliveira; Julhiany de Fátima da Silva; Liliana Scorzoni; Caroline M Marcos; Suelen A Rossi; Ana C A de Paula E Silva; Patrícia A Assato; Rosângela A M da Silva; Ana M Fusco-Almeida; Maria J S Mendes-Giannini
Journal:  Front Microbiol       Date:  2015-04-10       Impact factor: 5.640

Review 7.  Re-drawing the Maps for Endemic Mycoses.

Authors:  Nida Ashraf; Ryan C Kubat; Victoria Poplin; Antoine A Adenis; David W Denning; Laura Wright; Orion McCotter; Ilan S Schwartz; Brendan R Jackson; Tom Chiller; Nathan C Bahr
Journal:  Mycopathologia       Date:  2020-02-10       Impact factor: 2.574

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.